What's New on the FDA Drugs Site
March 23, 2016
- Drugs@FDA Data Files (updated
- FDA approves Cinqair to treat severe asthma
- FDA approves new psoriasis drug Taltz
- FDA Drug Shortages
- Calcium Gluconate Injection (Updated - Currently in Shortage)
- Chloramphenicol Sodium Succinate Injection (Updated -Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated -Currently in Shortage)
- Potassium Chloride Injection (Updated -Currently in Shortage)
- Sodium Acetate Injection, USP (New - Currently in Shortage)
- Vancomycin Hydrochloride for Injection, USP (Updated -Currently in Shortage)
- FDA Pharmacy Student Experiential Program (updated)
- FDA Warns Consumers Not to Use “Best Bentonite Clay”
- GDUFA Reauthorization Stakeholder Meetings (updated)
- Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies (updated)
- Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations (updated)
- The Voice of the Patient: A Series of Reports from FDA's Patient-Focused Drug Development Initiative(updated)
.png)
No hay comentarios:
Publicar un comentario